Stocks and Investing
Stocks and Investing
Fri, August 11, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, August 10, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Christopher Rigg Maintained (THC) at Strong Buy with Decreased Target to $24 on, Aug 10th, 2017
Christopher Rigg of Deutsche Bank, Maintained "Tenet Healthcare Corporation" (THC) at Strong Buy with Decreased Target from $28 to $24 on, Aug 10th, 2017.
Christopher has made no other calls on THC in the last 4 months.
There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 2 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Scott Fidel of "Credit Suisse" Maintained at Hold with Decreased Target to $17 on, Wednesday, August 9th, 2017
- Andrew Schenker of "Morgan Stanley" Initiated at Hold and Held Target at $19 on, Wednesday, June 7th, 2017
These are the ratings of the 2 analyists that currently disagree with Christopher
- Ana Gupte of "Leerink Swann" Upgraded from Hold to Buy and Held Target at $27 on, Wednesday, June 7th, 2017
- Gary Lieberman of "Wells Fargo" Upgraded from Hold to Buy on, Tuesday, June 6th, 2017
Contributing Sources